BRIEF published on 06/07/2024 at 14:05, 2 years 5 months ago Principle Diagnostics Celebrates 10 Years of Excellence in Pharmacogenomic Testing Genetic Testing Patient Outcomes Healthcare Innovation Personalized Medicine Pharmacogenomics
PRESS RELEASE published on 06/07/2024 at 14:00, 2 years 5 months ago Innovation in Pharmacogenomic Testing for Over a Decade Principle Diagnostics Laboratory celebrates a decade of pioneering advancements in personalized medicine through Pharmacogenomic (PGx) testing, optimizing medication efficacy and improving patient outcomes Innovation Patient Care Personalized Medicine Principle Diagnostics Laboratory Pharmacogenomic Testing
Published on 11/12/2026 at 01:40, 2 hours 47 minutes ago Nexteer Announces First Share Repurchase Programme of Up to US$60 Million
Published on 11/11/2026 at 23:30, 4 hours 57 minutes ago Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 5 hours 22 minutes ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 5 hours 27 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 5 hours 57 minutes ago 55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website
Published on 11/12/2026 at 02:20, 2 hours 6 minutes ago Nanjing Offers a Window into the Yangtze River's Cultural Heritage and Renewal
Published on 11/11/2026 at 19:29, 8 hours 58 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 9 hours 45 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 17:31, 1 day 10 hours ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day 14 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 17 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 21 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 2 days 9 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
